Stockscreener 앱 받기
3.3899
3.97%
0.1293
전일 마감가:
$3.2606
열려 있는:
$3.21
하루 거래량:
1,611
Relative Volume:
0.08
시가총액:
$471.71M
수익:
$16.82M
순이익/손실:
$-112.19M
주가수익비율:
-1.5282
EPS:
-2.2183
순현금흐름:
$-91.84M
1주 성능:
+1.22%
1개월 성능:
+0.92%
6개월 성능:
+56.94%
1년 성능:
+33.99%
1일 변동 폭
$3.21
$3.4225
1주일 범위
$3.21
$3.4847
52주 변동 폭
$1.53
$4.05
인벤티바 Stock (IVA) Company Profile
IVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
3.3899 | 465.79M | 16.82M | -112.19M | -91.84M | -2.2183 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.81 | 120.40B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.52 | 61.30B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.53 | 41.06B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
564.59 | 34.29B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.55 | 27.09B | 3.81B | -644.79M | -669.77M | -6.24 |
인벤티바 Stock (IVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-21 | 개시 | TD Cowen | Buy |
| 2024-11-12 | 개시 | UBS | Neutral |
| 2023-10-27 | 개시 | Canaccord Genuity | Buy |
| 2023-05-31 | 개시 | ROTH MKM | Buy |
| 2023-05-19 | 업그레이드 | Societe Generale | Sell → Buy |
| 2023-03-17 | 개시 | Stifel | Buy |
| 2022-11-15 | 다운그레이드 | Societe Generale | Buy → Sell |
| 2021-03-08 | 다운그레이드 | Societe Generale | Buy → Sell |
| 2020-08-05 | 개시 | ROTH Capital | Buy |
| 2020-08-04 | 개시 | Guggenheim | Buy |
| 2020-08-04 | 개시 | Stifel | Buy |
모두보기
인벤티바 주식(IVA)의 최신 뉴스
Wealth Enhancement Advisory Services LLC Acquires New Shares in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) - Defense World
Rokmaster Resources (CVE:RKR) Stock Price Up 71.4% – Still a Buy? - Defense World
Portofino Resources (CVE:POR) Trading Up 100% – Should You Buy? - Defense World
Portofino Resources (CVE:POR) Stock Price Up 100% – Time to Buy? - Defense World
Honey Badger Silver (CVE:TUF) Trading Down 12% – Here’s What Happened - Defense World
Voyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% – Here’s Why - Defense World
Northern Dynasty Minerals (TSE:NDM) Stock Price Up 25% – Time to Buy? - Defense World
Inventiva (NASDAQ:IVA) Trading 2.7% Higher – Here’s Why - Defense World
Inventiva (IVA) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Inventiva Participera à la « Jefferies Global Healthcare Conference » et à la « UBS Spring Biotech Conference » - GlobeNewswire Inc.
Inventiva sets share repurchase program terms post-meeting - Investing.com
Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Inventiva achieves milestone with Phase 3 study enrollment, says H.C. Wainwright - TipRanks
Stifel maintains Buy on Inventiva shares with $17 target - Investing.com
Inventiva SA ADR Reports 2024 Financial Results and Strategic Updates - TipRanks
Inventiva earnings missed by $0.03, revenue topped estimates - Investing.com
Top 10 Best Indian Companies In Smart Grids Solutions 2025 - Inventiva
Stifel reiterates Buy rating on Inventiva stock, cites financing deal - Investing.com
Inventiva (IVA) Loses -17.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Why Are Criminals Still in Power? 151 Lawmakers with Charges of Crimes Against Women Continue to Hold Office! Is This the End of Integrity in Indian Politics? - inventiva.co.in
Down -27.95% in 4 Weeks, Here's Why You Should You Buy the Dip in Inventiva (IVA) - Nasdaq
NOTA, No Votes and Unopposed Nominations: The Grey Areas of the Indian Election Process Explained - inventiva.co.in
symbol__ Stock Quote Price and Forecast - CNN
Supreme Court To Hear Plea Against Electoral Bonds From October 31 - Inventiva
Top 10 Best Handicraft Companies In USA 2023 - inventiva.co.in
Top 20 Best Hardware & Networking Company In India 2023 - inventiva.co.in
Inventiva SaAdr Share Price Today (NASDAQ: IVA)Inventiva SaAdr Stock Price Live Quote - INDmoney
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance
인벤티바 (IVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
0.34%
자본화:
|
볼륨(24시간):